img

Global Drug Eluting Beads Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Drug Eluting Beads Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.
The global Drug Eluting Beads market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The global drug eluting beads market is primarily driven by the increasing prevalence of liver diseases. Increasing awareness among people regarding the benefits of drug eluting beads therapy is also expected to drive the growth of the global drug eluting beads market. However, lack of skilled physicians is expected to restrain the market growth.
In terms of sales (consumption) side, this report focuses on the sales of Drug Eluting Beads by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Drug Eluting Beads market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Drug Eluting Beads market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Biocompatibles
BTG International
Merit Medical Systems
CeloNova BioSciences
ABK Biomedical
Boston Scientific
Medtronic
Merit Medical Systems
Surefire Medical
Terumo
By Type
Oncozene Beads
Quadra Sphere
LC Beads
Others
By Application
Hospitals
Specialized Clinics
Research Centers
Ambulatory Surgical Centers
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Drug Eluting Beads in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Eluting Beads sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Drug Eluting Beads Definition
1.2 Market by Type
1.2.1 Global Drug Eluting Beads Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oncozene Beads
1.2.3 Quadra Sphere
1.2.4 LC Beads
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Drug Eluting Beads Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Research Centers
1.3.5 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Drug Eluting Beads Sales
2.1 Global Drug Eluting Beads Revenue Estimates and Forecasts 2018-2034
2.2 Global Drug Eluting Beads Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Drug Eluting Beads Revenue by Region
2.3.1 Global Drug Eluting Beads Revenue by Region (2018-2024)
2.3.2 Global Drug Eluting Beads Revenue by Region (2024-2034)
2.4 Global Drug Eluting Beads Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Drug Eluting Beads Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Drug Eluting Beads Sales Quantity by Region
2.6.1 Global Drug Eluting Beads Sales Quantity by Region (2018-2024)
2.6.2 Global Drug Eluting Beads Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Drug Eluting Beads Sales Quantity by Manufacturers
3.1.1 Global Drug Eluting Beads Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Drug Eluting Beads Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Drug Eluting Beads Sales in 2022
3.2 Global Drug Eluting Beads Revenue by Manufacturers
3.2.1 Global Drug Eluting Beads Revenue by Manufacturers (2018-2024)
3.2.2 Global Drug Eluting Beads Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Drug Eluting Beads Revenue in 2022
3.3 Global Drug Eluting Beads Sales Price by Manufacturers
3.4 Global Key Players of Drug Eluting Beads, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Drug Eluting Beads, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Drug Eluting Beads, Product Offered and Application
3.8 Global Key Manufacturers of Drug Eluting Beads, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Drug Eluting Beads Sales Quantity by Type
4.1.1 Global Drug Eluting Beads Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Drug Eluting Beads Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Drug Eluting Beads Sales Quantity Market Share by Type (2018-2034)
4.2 Global Drug Eluting Beads Revenue by Type
4.2.1 Global Drug Eluting Beads Historical Revenue by Type (2018-2024)
4.2.2 Global Drug Eluting Beads Forecasted Revenue by Type (2024-2034)
4.2.3 Global Drug Eluting Beads Revenue Market Share by Type (2018-2034)
4.3 Global Drug Eluting Beads Price by Type
4.3.1 Global Drug Eluting Beads Price by Type (2018-2024)
4.3.2 Global Drug Eluting Beads Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Drug Eluting Beads Sales Quantity by Application
5.1.1 Global Drug Eluting Beads Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Drug Eluting Beads Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Drug Eluting Beads Sales Quantity Market Share by Application (2018-2034)
5.2 Global Drug Eluting Beads Revenue by Application
5.2.1 Global Drug Eluting Beads Historical Revenue by Application (2018-2024)
5.2.2 Global Drug Eluting Beads Forecasted Revenue by Application (2024-2034)
5.2.3 Global Drug Eluting Beads Revenue Market Share by Application (2018-2034)
5.3 Global Drug Eluting Beads Price by Application
5.3.1 Global Drug Eluting Beads Price by Application (2018-2024)
5.3.2 Global Drug Eluting Beads Price Forecast by Application (2024-2034)
6 North America
6.1 North America Drug Eluting Beads Sales by Company
6.1.1 North America Drug Eluting Beads Revenue by Company (2018-2024)
6.1.2 North America Drug Eluting Beads Sales Quantity by Company (2018-2024)
6.2 North America Drug Eluting Beads Market Size by Type
6.2.1 North America Drug Eluting Beads Sales Quantity by Type (2018-2034)
6.2.2 North America Drug Eluting Beads Revenue by Type (2018-2034)
6.3 North America Drug Eluting Beads Market Size by Application
6.3.1 North America Drug Eluting Beads Sales Quantity by Application (2018-2034)
6.3.2 North America Drug Eluting Beads Revenue by Application (2018-2034)
6.4 North America Drug Eluting Beads Market Size by Country
6.4.1 North America Drug Eluting Beads Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Drug Eluting Beads Revenue by Country (2018-2034)
6.4.3 North America Drug Eluting Beads Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Drug Eluting Beads Sales by Company
7.1.1 Europe Drug Eluting Beads Sales Quantity by Company (2018-2024)
7.1.2 Europe Drug Eluting Beads Revenue by Company (2018-2024)
7.2 Europe Drug Eluting Beads Market Size by Type
7.2.1 Europe Drug Eluting Beads Sales Quantity by Type (2018-2034)
7.2.2 Europe Drug Eluting Beads Revenue by Type (2018-2034)
7.3 Europe Drug Eluting Beads Market Size by Application
7.3.1 Europe Drug Eluting Beads Sales Quantity by Application (2018-2034)
7.3.2 Europe Drug Eluting Beads Revenue by Application (2018-2034)
7.4 Europe Drug Eluting Beads Market Size by Country
7.4.1 Europe Drug Eluting Beads Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Drug Eluting Beads Revenue by Country (2018-2034)
7.4.3 Europe Drug Eluting Beads Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Drug Eluting Beads Sales by Company
8.1.1 China Drug Eluting Beads Sales Quantity by Company (2018-2024)
8.1.2 China Drug Eluting Beads Revenue by Company (2018-2024)
8.2 China Drug Eluting Beads Market Size by Type
8.2.1 China Drug Eluting Beads Sales Quantity by Type (2018-2034)
8.2.2 China Drug Eluting Beads Revenue by Type (2018-2034)
8.3 China Drug Eluting Beads Market Size by Application
8.3.1 China Drug Eluting Beads Sales Quantity by Application (2018-2034)
8.3.2 China Drug Eluting Beads Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Drug Eluting Beads Sales by Company
9.1.1 APAC Drug Eluting Beads Sales Quantity by Company (2018-2024)
9.1.2 APAC Drug Eluting Beads Revenue by Company (2018-2024)
9.2 APAC Drug Eluting Beads Market Size by Type
9.2.1 APAC Drug Eluting Beads Sales Quantity by Type (2018-2034)
9.2.2 APAC Drug Eluting Beads Revenue by Type (2018-2034)
9.3 APAC Drug Eluting Beads Market Size by Application
9.3.1 APAC Drug Eluting Beads Sales Quantity by Application (2018-2034)
9.3.2 APAC Drug Eluting Beads Revenue by Application (2018-2034)
9.4 APAC Drug Eluting Beads Market Size by Region
9.4.1 APAC Drug Eluting Beads Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Drug Eluting Beads Revenue by Region (2018-2034)
9.4.3 APAC Drug Eluting Beads Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Drug Eluting Beads Sales by Company
10.1.1 Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Drug Eluting Beads Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Drug Eluting Beads Market Size by Type
10.2.1 Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Drug Eluting Beads Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Drug Eluting Beads Market Size by Application
10.3.1 Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Drug Eluting Beads Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Drug Eluting Beads Market Size by Country
10.4.1 Middle East, Africa and Latin America Drug Eluting Beads Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Drug Eluting Beads Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Biocompatibles
11.1.1 Biocompatibles Company Information
11.1.2 Biocompatibles Overview
11.1.3 Biocompatibles Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Biocompatibles Drug Eluting Beads Products and Services
11.1.5 Biocompatibles Drug Eluting Beads SWOT Analysis
11.1.6 Biocompatibles Recent Developments
11.2 BTG International
11.2.1 BTG International Company Information
11.2.2 BTG International Overview
11.2.3 BTG International Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 BTG International Drug Eluting Beads Products and Services
11.2.5 BTG International Drug Eluting Beads SWOT Analysis
11.2.6 BTG International Recent Developments
11.3 Merit Medical Systems
11.3.1 Merit Medical Systems Company Information
11.3.2 Merit Medical Systems Overview
11.3.3 Merit Medical Systems Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Merit Medical Systems Drug Eluting Beads Products and Services
11.3.5 Merit Medical Systems Drug Eluting Beads SWOT Analysis
11.3.6 Merit Medical Systems Recent Developments
11.4 CeloNova BioSciences
11.4.1 CeloNova BioSciences Company Information
11.4.2 CeloNova BioSciences Overview
11.4.3 CeloNova BioSciences Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 CeloNova BioSciences Drug Eluting Beads Products and Services
11.4.5 CeloNova BioSciences Drug Eluting Beads SWOT Analysis
11.4.6 CeloNova BioSciences Recent Developments
11.5 ABK Biomedical
11.5.1 ABK Biomedical Company Information
11.5.2 ABK Biomedical Overview
11.5.3 ABK Biomedical Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 ABK Biomedical Drug Eluting Beads Products and Services
11.5.5 ABK Biomedical Drug Eluting Beads SWOT Analysis
11.5.6 ABK Biomedical Recent Developments
11.6 Boston Scientific
11.6.1 Boston Scientific Company Information
11.6.2 Boston Scientific Overview
11.6.3 Boston Scientific Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Boston Scientific Drug Eluting Beads Products and Services
11.6.5 Boston Scientific Drug Eluting Beads SWOT Analysis
11.6.6 Boston Scientific Recent Developments
11.7 Medtronic
11.7.1 Medtronic Company Information
11.7.2 Medtronic Overview
11.7.3 Medtronic Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Medtronic Drug Eluting Beads Products and Services
11.7.5 Medtronic Drug Eluting Beads SWOT Analysis
11.7.6 Medtronic Recent Developments
11.8 Merit Medical Systems
11.8.1 Merit Medical Systems Company Information
11.8.2 Merit Medical Systems Overview
11.8.3 Merit Medical Systems Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Merit Medical Systems Drug Eluting Beads Products and Services
11.8.5 Merit Medical Systems Drug Eluting Beads SWOT Analysis
11.8.6 Merit Medical Systems Recent Developments
11.9 Surefire Medical
11.9.1 Surefire Medical Company Information
11.9.2 Surefire Medical Overview
11.9.3 Surefire Medical Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Surefire Medical Drug Eluting Beads Products and Services
11.9.5 Surefire Medical Drug Eluting Beads SWOT Analysis
11.9.6 Surefire Medical Recent Developments
11.10 Terumo
11.10.1 Terumo Company Information
11.10.2 Terumo Overview
11.10.3 Terumo Drug Eluting Beads Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Terumo Drug Eluting Beads Products and Services
11.10.5 Terumo Drug Eluting Beads SWOT Analysis
11.10.6 Terumo Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Drug Eluting Beads Value Chain Analysis
12.2 Drug Eluting Beads Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Eluting Beads Production Mode & Process
12.4 Drug Eluting Beads Sales and Marketing
12.4.1 Drug Eluting Beads Sales Channels
12.4.2 Drug Eluting Beads Distributors
12.5 Drug Eluting Beads Customers
13 Market Dynamics
13.1 Drug Eluting Beads Industry Trends
13.2 Drug Eluting Beads Market Drivers
13.3 Drug Eluting Beads Market Challenges
13.4 Drug Eluting Beads Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Drug Eluting Beads Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oncozene Beads
Table 3. Major Manufacturers of Quadra Sphere
Table 4. Major Manufacturers of LC Beads
Table 5. Major Manufacturers of Others
Table 6. Global Drug Eluting Beads Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Drug Eluting Beads Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Drug Eluting Beads Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Drug Eluting Beads Revenue Market Share by Region (2018-2024)
Table 10. Global Drug Eluting Beads Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Drug Eluting Beads Revenue Market Share by Region (2024-2034)
Table 12. Global Drug Eluting Beads Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 13. Global Drug Eluting Beads Sales by Region (2018-2024) & (K Units)
Table 14. Global Drug Eluting Beads Sales Market Share by Region (2018-2024)
Table 15. Global Drug Eluting Beads Sales by Region (2024-2034) & (K Units)
Table 16. Global Drug Eluting Beads Sales Market Share by Region (2024-2034)
Table 17. Global Drug Eluting Beads Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 18. Global Drug Eluting Beads Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Drug Eluting Beads Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Drug Eluting Beads Revenue Share by Manufacturers (2018-2024)
Table 21. Global Drug Eluting Beads Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Key Players of Drug Eluting Beads, Industry Ranking, 2021 VS 2022
Table 23. Global Drug Eluting Beads Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Drug Eluting Beads by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Beads as of 2022)
Table 25. Global Key Manufacturers of Drug Eluting Beads, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Drug Eluting Beads, Product Offered and Application
Table 27. Global Key Manufacturers of Drug Eluting Beads, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Drug Eluting Beads Sales Quantity by Type (2018-2024) & (K Units)
Table 30. Global Drug Eluting Beads Sales Quantity by Type (2024-2034) & (K Units)
Table 31. Global Drug Eluting Beads Sales Quantity Share by Type (2018-2024)
Table 32. Global Drug Eluting Beads Sales Quantity Share by Type (2024-2034)
Table 33. Global Drug Eluting Beads Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Drug Eluting Beads Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Drug Eluting Beads Revenue Share by Type (2018-2024)
Table 36. Global Drug Eluting Beads Revenue Share by Type (2024-2034)
Table 37. Drug Eluting Beads Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Drug Eluting Beads Price Forecast by Type (2024-2034) & (USD/Unit)
Table 39. Global Drug Eluting Beads Sales Quantity by Application (2018-2024) & (K Units)
Table 40. Global Drug Eluting Beads Sales Quantity by Application (2024-2034) & (K Units)
Table 41. Global Drug Eluting Beads Sales Quantity Share by Application (2018-2024)
Table 42. Global Drug Eluting Beads Sales Quantity Share by Application (2024-2034)
Table 43. Global Drug Eluting Beads Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Drug Eluting Beads Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Drug Eluting Beads Revenue Share by Application (2018-2024)
Table 46. Global Drug Eluting Beads Revenue Share by Application (2024-2034)
Table 47. Drug Eluting Beads Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Drug Eluting Beads Price Forecast by Application (2024-2034) & (USD/Unit)
Table 49. North America Drug Eluting Beads Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Drug Eluting Beads Sales Quantity by Company (2018-2024) & (K Units)
Table 51. North America Drug Eluting Beads Sales Quantity by Type (2018-2024) & (K Units)
Table 52. North America Drug Eluting Beads Sales Quantity by Type (2024-2034) & (K Units)
Table 53. North America Drug Eluting Beads Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Drug Eluting Beads Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Drug Eluting Beads Sales Quantity by Application (2018-2024) & (K Units)
Table 56. North America Drug Eluting Beads Sales Quantity by Application (2024-2034) & (K Units)
Table 57. North America Drug Eluting Beads Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Drug Eluting Beads Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Drug Eluting Beads Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Drug Eluting Beads Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Drug Eluting Beads Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Drug Eluting Beads Sales Quantity by Country (2018-2024) & (K Units)
Table 63. North America Drug Eluting Beads Sales Quantity by Country (2024-2034) & (K Units)
Table 64. Europe Drug Eluting Beads Sales Quantity by Company (2018-2024) & (K Units)
Table 65. Europe Drug Eluting Beads Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Drug Eluting Beads Sales Quantity by Type (2018-2024) & (K Units)
Table 67. Europe Drug Eluting Beads Sales Quantity by Type (2024-2034) & (K Units)
Table 68. Europe Drug Eluting Beads Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Drug Eluting Beads Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Drug Eluting Beads Sales Quantity by Application (2018-2024) & (K Units)
Table 71. Europe Drug Eluting Beads Sales Quantity by Application (2024-2034) & (K Units)
Table 72. Europe Drug Eluting Beads Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Drug Eluting Beads Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Drug Eluting Beads Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Drug Eluting Beads Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Drug Eluting Beads Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Drug Eluting Beads Sales Quantity by Country (2018-2024) & (K Units)
Table 78. Europe Drug Eluting Beads Sales Quantity by Country (2024-2034) & (K Units)
Table 79. China Drug Eluting Beads Sales Quantity by Company (2018-2024) & (K Units)
Table 80. China Drug Eluting Beads Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Drug Eluting Beads Sales Quantity by Type (2018-2024) & (K Units)
Table 82. China Drug Eluting Beads Sales Quantity by Type (2024-2034) & (K Units)
Table 83. China Drug Eluting Beads Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Drug Eluting Beads Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Drug Eluting Beads Sales Quantity by Application (2018-2024) & (K Units)
Table 86. China Drug Eluting Beads Sales Quantity by Application (2024-2034) & (K Units)
Table 87. China Drug Eluting Beads Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Drug Eluting Beads Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Drug Eluting Beads Sales Quantity by Company (2018-2024) & (K Units)
Table 90. APAC Drug Eluting Beads Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Drug Eluting Beads Sales Quantity by Type (2018-2024) & (K Units)
Table 92. APAC Drug Eluting Beads Sales Quantity by Type (2024-2034) & (K Units)
Table 93. APAC Drug Eluting Beads Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Drug Eluting Beads Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Drug Eluting Beads Sales Quantity by Application (2018-2024) & (K Units)
Table 96. APAC Drug Eluting Beads Sales Quantity by Application (2024-2034) & (K Units)
Table 97. APAC Drug Eluting Beads Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Drug Eluting Beads Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Drug Eluting Beads Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Drug Eluting Beads Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Drug Eluting Beads Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Drug Eluting Beads Sales Quantity by Region (2018-2024) & (K Units)
Table 103. APAC Drug Eluting Beads Sales Quantity by Region (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Company (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Type (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Type (2024-2034) & (K Units)
Table 108. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Application (2018-2024) & (K Units)
Table 111. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Application (2024-2034) & (K Units)
Table 112. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Drug Eluting Beads Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Country (2018-2024) & (K Units)
Table 118. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity by Country (2024-2034) & (K Units)
Table 119. Biocompatibles Company Information
Table 120. Biocompatibles Description and Overview
Table 121. Biocompatibles Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 122. Biocompatibles Drug Eluting Beads Product and Services
Table 123. Biocompatibles Drug Eluting Beads SWOT Analysis
Table 124. Biocompatibles Recent Developments
Table 125. BTG International Company Information
Table 126. BTG International Description and Overview
Table 127. BTG International Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 128. BTG International Drug Eluting Beads Product and Services
Table 129. BTG International Drug Eluting Beads SWOT Analysis
Table 130. BTG International Recent Developments
Table 131. Merit Medical Systems Company Information
Table 132. Merit Medical Systems Description and Overview
Table 133. Merit Medical Systems Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 134. Merit Medical Systems Drug Eluting Beads Product and Services
Table 135. Merit Medical Systems Drug Eluting Beads SWOT Analysis
Table 136. Merit Medical Systems Recent Developments
Table 137. CeloNova BioSciences Company Information
Table 138. CeloNova BioSciences Description and Overview
Table 139. CeloNova BioSciences Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 140. CeloNova BioSciences Drug Eluting Beads Product and Services
Table 141. CeloNova BioSciences Drug Eluting Beads SWOT Analysis
Table 142. CeloNova BioSciences Recent Developments
Table 143. ABK Biomedical Company Information
Table 144. ABK Biomedical Description and Overview
Table 145. ABK Biomedical Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 146. ABK Biomedical Drug Eluting Beads Product and Services
Table 147. ABK Biomedical Drug Eluting Beads SWOT Analysis
Table 148. ABK Biomedical Recent Developments
Table 149. Boston Scientific Company Information
Table 150. Boston Scientific Description and Overview
Table 151. Boston Scientific Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 152. Boston Scientific Drug Eluting Beads Product and Services
Table 153. Boston Scientific Drug Eluting Beads SWOT Analysis
Table 154. Boston Scientific Recent Developments
Table 155. Medtronic Company Information
Table 156. Medtronic Description and Overview
Table 157. Medtronic Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 158. Medtronic Drug Eluting Beads Product and Services
Table 159. Medtronic Drug Eluting Beads SWOT Analysis
Table 160. Medtronic Recent Developments
Table 161. Merit Medical Systems Company Information
Table 162. Merit Medical Systems Description and Overview
Table 163. Merit Medical Systems Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 164. Merit Medical Systems Drug Eluting Beads Product and Services
Table 165. Merit Medical Systems Drug Eluting Beads SWOT Analysis
Table 166. Merit Medical Systems Recent Developments
Table 167. Surefire Medical Company Information
Table 168. Surefire Medical Description and Overview
Table 169. Surefire Medical Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 170. Surefire Medical Drug Eluting Beads Product and Services
Table 171. Surefire Medical Drug Eluting Beads SWOT Analysis
Table 172. Surefire Medical Recent Developments
Table 173. Terumo Company Information
Table 174. Terumo Description and Overview
Table 175. Terumo Drug Eluting Beads Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 176. Terumo Drug Eluting Beads Product and Services
Table 177. Terumo Drug Eluting Beads SWOT Analysis
Table 178. Terumo Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Drug Eluting Beads Distributors List
Table 182. Drug Eluting Beads Customers List
Table 183. Drug Eluting Beads Market Trends
Table 184. Drug Eluting Beads Market Drivers
Table 185. Drug Eluting Beads Market Challenges
Table 186. Drug Eluting Beads Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Eluting Beads Product Picture
Figure 2. Global Drug Eluting Beads Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Drug Eluting Beads Market Share by Type in 2022 & 2034
Figure 4. Oncozene Beads Product Picture
Figure 5. Quadra Sphere Product Picture
Figure 6. LC Beads Product Picture
Figure 7. Others Product Picture
Figure 8. Global Drug Eluting Beads Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Drug Eluting Beads Market Share by Application in 2022 & 2034
Figure 10. Hospitals
Figure 11. Specialized Clinics
Figure 12. Research Centers
Figure 13. Ambulatory Surgical Centers
Figure 14. Drug Eluting Beads Report Years Considered
Figure 15. Global Drug Eluting Beads Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Drug Eluting Beads Revenue 2018-2034 (US$ Million)
Figure 17. Global Drug Eluting Beads Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Drug Eluting Beads Sales Quantity 2018-2034 (K Units)
Figure 19. Global Drug Eluting Beads Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Drug Eluting Beads Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Drug Eluting Beads Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. North America Drug Eluting Beads Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Drug Eluting Beads Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. Europe Drug Eluting Beads Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Drug Eluting Beads Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. China Drug Eluting Beads Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Drug Eluting Beads Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. APAC Drug Eluting Beads Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity YoY (2018-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America Drug Eluting Beads Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Drug Eluting Beads Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Drug Eluting Beads Revenue in 2022
Figure 33. Drug Eluting Beads Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Drug Eluting Beads Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Drug Eluting Beads Revenue Market Share by Type (2018-2034)
Figure 36. Global Drug Eluting Beads Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Drug Eluting Beads Revenue Market Share by Application (2018-2034)
Figure 38. North America Drug Eluting Beads Revenue Market Share by Company in 2022
Figure 39. North America Drug Eluting Beads Sales Quantity Market Share by Company in 2022
Figure 40. North America Drug Eluting Beads Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Drug Eluting Beads Revenue Market Share by Type (2018-2034)
Figure 42. North America Drug Eluting Beads Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Drug Eluting Beads Revenue Market Share by Application (2018-2034)
Figure 44. North America Drug Eluting Beads Revenue Share by Country (2018-2034)
Figure 45. North America Drug Eluting Beads Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Drug Eluting Beads Sales Quantity Market Share by Company in 2022
Figure 49. Europe Drug Eluting Beads Revenue Market Share by Company in 2022
Figure 50. Europe Drug Eluting Beads Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Drug Eluting Beads Revenue Market Share by Type (2018-2034)
Figure 52. Europe Drug Eluting Beads Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Drug Eluting Beads Revenue Market Share by Application (2018-2034)
Figure 54. Europe Drug Eluting Beads Revenue Share by Country (2018-2034)
Figure 55. Europe Drug Eluting Beads Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 57. France Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 61. China Drug Eluting Beads Sales Quantity Market Share by Company in 2022
Figure 62. China Drug Eluting Beads Revenue Market Share by Company in 2022
Figure 63. China Drug Eluting Beads Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Drug Eluting Beads Revenue Market Share by Type (2018-2034)
Figure 65. China Drug Eluting Beads Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Drug Eluting Beads Revenue Market Share by Application (2018-2034)
Figure 67. APAC Drug Eluting Beads Sales Quantity Market Share by Company in 2022
Figure 68. APAC Drug Eluting Beads Revenue Market Share by Company in 2022
Figure 69. APAC Drug Eluting Beads Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Drug Eluting Beads Revenue Market Share by Type (2018-2034)
Figure 71. APAC Drug Eluting Beads Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Drug Eluting Beads Revenue Market Share by Application (2018-2034)
Figure 73. APAC Drug Eluting Beads Revenue Share by Region (2018-2034)
Figure 74. APAC Drug Eluting Beads Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 79. India Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Drug Eluting Beads Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Drug Eluting Beads Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Drug Eluting Beads Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Drug Eluting Beads Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Drug Eluting Beads Revenue Share by Country (2018-2034)
Figure 88. Brazil Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Drug Eluting Beads Revenue (2018-2034) & (US$ Million)
Figure 93. Drug Eluting Beads Value Chain
Figure 94. Drug Eluting Beads Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries